Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study[S]

Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study[S]

Hypertriglyceridemia, defined as a triglyceride measurement > 150 mg/dl, occurs in up to 34% of adults. Fenofibrate is a commonly used drug to treat hypertriglyceridemia, but response to fenofibrate varies considerably among individuals. We sought to determine if genetic variation in apolipoprote...

Full description

Bibliographic Details
Main Authors: Mary K. Wojczynski, Guimin Gao, Ingrid Borecki, Paul N. Hopkins, Laurence Parnell, Chao-Qiang Lai, Jose M. Ordovas, B. Hong Chung, Donna K. Arnett
Format: Article
Language:English
Published: Elsevier 2010-11-01
Series:Journal of Lipid Research
Subjects:
fenofibrate
polymorphism
triglycerides
Genetics of Lipid Lowering Drugs and Diet Network
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520409654

Internet

http://www.sciencedirect.com/science/article/pii/S0022227520409654

Similar Items